Beta-alanine powder should be evaluated through chemical identity, assay methodology, process-related impurities, contaminant controls, and formulation-relevant physical properties. Before approving a supplier, buyers should also verify the manufacturing source, lot-specific COA, packaging, shelf life, change-control process, and ability to provide consistent commercial batches.
A stated purity percentage does not show whether an ingredient will blend, fill, dissolve, or remain stable in a finished product.
For formulators, quality means predictable performance in the intended dosage form. For quality teams, it means defensible test methods and traceable records. For procurement teams, it means balancing price with testing costs, production risk, lead time, and supply continuity.
Beta-Alanine Powder Buyer Quick Reference
| Parameter | Typical reference |
|---|---|
| Chemical name | 3-Aminopropanoic acid |
| CAS number | 107-95-9 |
| Appearance | White to off-white crystalline powder |
| Typical assay | 98.5%–101.0% on a dry basis |
| Typical particle size | Fine powder around 80 mesh |
| Standard carrier | Carrier-free |
| Main applications | Powders, capsules, tablets, sachets, and stick packs |
These values summarize the current reference information on the Essencefield beta-alanine powder product page. Final specifications, analytical methods, documents, and packaging should be confirmed for the selected grade, lot, application, and destination market.
What Is Beta-Alanine Powder Used For?
Beta-alanine is a non-proteinogenic amino acid used primarily in sports nutrition formulations. It is structurally different from L-alanine, although both materials may appear as white crystalline powders.
The PubChem beta-alanine record identifies the compound as 3-aminopropanoic acid with CAS number 107-95-9. Buyers sourcing several amino acid ingredients can review the distinction in Essencefield’s L-alanine and beta-alanine comparison.
In the body, beta-alanine contributes to the synthesis of carnosine in skeletal muscle. Carnosine is involved in intracellular acid-base buffering, making beta-alanine relevant to formulas intended for selected high-intensity exercise conditions.
The NIH Office of Dietary Supplements reports that supplementation may produce small or inconsistent performance benefits depending on exercise type, supplementation period, training status, and study design. Evidence is generally most relevant to demanding exercise lasting roughly one to four minutes.
This supports careful positioning around:
- Muscle carnosine synthesis
- High-intensity exercise applications
- Repeated-effort sports nutrition
- Stimulant and stimulant-free pre-workout systems
Evidence does not consistently support direct claims for muscle growth, fat loss, body-composition improvement, or universal endurance enhancement.
For products marketed in the United States, the FDA guidance on dietary-supplement claim substantiation states that claims should be truthful, not misleading, and supported by appropriate evidence.
Formulation and tolerance considerations
Beta-alanine powder is particularly practical in dry formulations because research-associated serving levels may be difficult to accommodate in a small number of capsules or tablets.
It is commonly considered for:
- Pre-workout powder blends
- Amino acid complexes
- Capsules and tablets
- Stick packs and sachets
- Flavored beverage powders
Paresthesia is the temporary tingling or prickling sensation sometimes associated with rapid-release beta-alanine. It is a tolerance consideration rather than a purity or efficacy test.
Finished-product developers may evaluate divided servings, delivery format, serving instructions, and consumer communication. Tingling should not be presented as proof that a formula is effective.
Which Beta-Alanine Powder Specifications Matter Most?
A commercial specification should be designed from the finished application backward.
Before approving a grade, define:
- Intended dosage form
- Target serving level
- Destination market
- Finished-product contaminant limits
- Processing equipment
- Packaging system
- Stability expectations
- Required declarations
- Incoming-testing strategy
For U.S. dietary supplements, the FDA dietary-supplement CGMP guide explains that manufacturers must establish component and finished-product specifications and determine whether those specifications are met.
Identity and assay
Identity confirms that an incoming material is beta-alanine rather than another amino acid or visually similar powder.
A controlled specification should identify:
- Chemical name and CAS number
- Product or grade code
- Identity procedure
- Reference standard
- Test-method version
- Responsible laboratory
Appearance alone cannot establish identity.
Assay measures the beta-alanine content according to a defined analytical procedure and calculation basis. Essencefield currently lists a typical dry-basis assay of 98.5%–101.0%, subject to the selected specification and agreed method.
When comparing assay data, buyers should confirm:
- The test method and reference standard
- Whether the result is dry basis or as received
- The actual numerical lot result
- Whether related substances are controlled separately
A higher assay result does not automatically indicate better quality.
For example, a 99.6% result produced by a nonspecific method may provide less useful information than a 99.2% result from a validated chromatographic method capable of separating relevant related substances.
Identity, assay, and impurity profile answer different quality questions.
Purity and process-related controls
Commercial beta-alanine powder may be produced through controlled synthesis followed by purification, crystallization, drying, and milling.
Relevant controls can be grouped into:
- Moisture and inorganic residue
- Related substances and reaction by-products
- Residual solvents, reagents, and route-specific residues
Essencefield currently lists loss on drying at typically no more than 0.50% and residue on ignition at typically no more than 0.20%, subject to the approved specification.
Moisture is commercially important because excessive or variable levels can contribute to:
- Caking
- Poor flow
- Inconsistent weighing
- Altered assay calculations
- Reduced storage stability
Not every process-related parameter needs to appear on every routine COA. However, the supplier should be able to explain which impurities are expected, how they are controlled, and which parameters are tested routinely or periodically.
Elemental and microbiological quality
Current Essencefield reference specifications present the following typical elemental limits:
| Element | Typical limit |
|---|---|
| Lead | NMT 0.5 ppm |
| Arsenic | NMT 0.5 ppm |
| Cadmium | NMT 0.3 ppm |
| Mercury | NMT 0.1 ppm |
These are supplier reference values rather than universal regulatory limits. Final limits should reflect the maximum finished-product serving and destination-market requirements.
Typical microbiological reference controls include:
| Test | Typical limit |
|---|---|
| Total plate count | NMT 1,000 CFU/g |
| Yeast and mold | NMT 100 CFU/g |
| E. coli | Negative in 10 g |
| Salmonella | Negative in 25 g |
Buyers should confirm individual numerical elemental results, method capability, pathogen criteria, and whether the raw-material limits support the intended finished product.
A generic “total heavy metals” result may not provide enough information to assess lead, arsenic, cadmium, and mercury independently.
How to Evaluate a Beta-Alanine COA
A beta-alanine COA should connect the physical shipment to a defined product, specification, test method, result, lot number, and quality-release decision.
It should not function as a generic marketing document.
COA evaluation matrix
| COA field | Acceptable evidence | Warning sign | Buyer action |
|---|---|---|---|
| Product identity | Exact name, grade, and identity method | Appearance only | Request a specific identity test |
| Lot number | Matches packages and shipping records | Missing or inconsistent number | Hold the shipment |
| Assay | Numerical result, method, and basis | Purity claim only | Request the lot result |
| Purity controls | Numerical moisture or impurity data | Results copied from limits | Review test data |
| Contaminants | Individual elemental and microbial results | “Pass” or total metals only | Confirm results and methods |
| Specification | Controlled revision | Undated document | Request the approved version |
| Laboratory | Testing responsibility identified | Laboratory unclear | Confirm testing scope |
| Quality release | Authorized quality approval | Sales signature only | Request formal release evidence |
Why the analytical method matters
An assay value should always be interpreted in the context of the method used to produce it.
A nonspecific procedure may measure beta-alanine together with chemically related substances. A suitable chromatographic method may provide more information about identity, assay, and impurity separation, even when its final numerical result is slightly lower.
Buyers should therefore compare:
- Method specificity
- Validation or verification status
- Reference standard
- Reporting basis
- Measurement capability
- Actual lot variation
High-risk COA signals
Further investigation is appropriate when:
- Numerical results are identical across numerous lots.
- Results repeatedly match the specification limit exactly.
- Test methods are missing or described only as “in-house.”
- Product or facility names differ among documents.
- COA and package lot numbers do not match.
- Acceptance limits are below the laboratory’s measurement capability.
The COA should also be checked against the purchase order, package labels, packing list, specification, and shipping records.
Essencefield describes its raw-material quality process as connecting supplier qualification, specification confirmation, COA review, incoming inspection, material release, and batch traceability.
How Physical Properties Affect the Dosage Form
Two lots can meet the same chemical assay and still behave differently during production.
| Dosage form | Critical attributes | Main risk |
|---|---|---|
| Pre-workout powder | Particle size, density, flow, taste, dissolution | Segregation or scoop variation |
| Capsule | Bulk density, flow, fill weight | Variable filling or excessive capsule count |
| Tablet | Particle size, compressibility, lubrication response | Sticking, capping, or poor hardness |
| Stick pack | Flow, dust, moisture sensitivity | Bridging or inaccurate filling |
| Beverage powder | Solubility, taste, pH compatibility | Sediment or slow dissolution |
| Multi-active blend | Density and particle-size compatibility | Active segregation |
Particle size and segregation
Essencefield commonly lists beta-alanine powder at approximately 80 mesh, while project-specific particle-size control may be available.
Very fine particles may increase dust, static behavior, poor flow, and equipment loss. Coarser particles may segregate from finer ingredients or dissolve more slowly.
Mesh size is only a screening reference. Higher-risk formulations may require a complete particle-size distribution and pilot-scale blend assessment.
Density and filling behavior
Density affects package volume, hopper behavior, fill accuracy, and segregation risk.
When beta-alanine has a substantially different density from lower-dose ingredients, separation can occur during:
- Blending
- Transfer
- Hopper holding
- Filling
- Shipping
Pilot blending and stratified sampling provide more useful evidence than visual inspection alone.
Solubility and sensory validation
The material is generally described as freely soluble in water, but finished-product performance should still be evaluated at the intended concentration, pH, mixing conditions, flavor system, and holding time.
A result in plain water does not predict behavior in a formula containing acids, sweeteners, caffeine, minerals, colors, or other amino acids.
Essencefield’s project workflow includes technical review of application-relevant properties before commercial production.
Five Gates for Beta-Alanine Supplier Approval
Gate 1: Source transparency
Confirm the legal seller, original manufacturer, manufacturing site, testing site, and any repacking operation.
A distributor or trading company can be an acceptable supplier, but the buyer should still know who manufactures and releases the material.
An undisclosed source change can invalidate:
- Sample approval
- Audit findings
- Specification agreements
- Historical test data
- Pilot-production results
Gate 2: Specification and analytical control
Confirm that the approved specification, methods, and laboratory capability support the intended dosage form and target market.
The review should connect:
- Identity
- Assay
- Impurity controls
- Contaminant limits
- Physical requirements
- Packaging
- Shelf life
Essencefield’s testing and certification support may cover identity, assay, moisture, particle size, microbiology, and risk-based contaminants according to the ingredient and project.
Independent testing may also be coordinated when required. Certification availability should be verified by product, facility, scope, issuer, and validity date.
Gate 3: Representative sample and pilot suitability
The qualification sample should represent the intended commercial source, grade, specification, and particle profile.
Risk-based laboratory testing may be followed by a pilot trial reviewing:
- Blend uniformity
- Powder feeding and filling
- Dust generation
- Dissolution or sensory performance
- Packaging compatibility
A chemically compliant material may still be unsuitable if it causes poor flow, segregation, slow dissolution, excessive dust, or unacceptable flavor.
Gate 4: Quality-system control
Review whether the supplier maintains workable procedures for:
- Deviations
- Corrective and preventive action
- Complaints
- Product holds
- Document control
- Traceability
- Recall support
- Change notification
The quality agreement should define notification requirements for changes involving the site, process, starting materials, specification, analytical methods, packaging, or shelf life.
Approved-supplier status should not eliminate incoming controls.
Gate 5: Commercial continuity
Evaluate:
- MOQ
- Standard and custom lead time
- Repeat-order capacity
- Safety-stock options
- Response during deviations
A technically acceptable supplier can still create significant business risk if documentation, lead time, or batch consistency is unreliable.
Documents, Packaging, and Commercial Supply
Core documents
A qualification package should normally include:
- Approved specification
- Representative COA
- Lot-specific COA
- Technical data sheet
- Safety data sheet
- Country-of-origin statement
Depending on the market and application, buyers may also request allergen, GMO, vegan, gluten, irradiation, residual-solvent, or other relevant declarations.
Document availability should be confirmed for the exact grade and manufacturing source.
Packaging and shelf life
Current Essencefield information describes:
- Sealed sample bags
- Food-grade inner PE bags
- Drums, cartons, or project-specific export packing
- A common 25 kg bulk size
- A typical unopened shelf life of 24 months
The powder should be stored sealed in a cool, dry, clean environment and protected from moisture, excessive heat, direct sunlight, and strong odors.
At receiving, confirm that the package label, COA, packing list, and purchase order show consistent product and lot information.
MOQ, samples, and lead time
Current project-planning references include:
- Typical MOQ: 25 kg
- Samples: subject to project review
- Typical stock lead time: one to two weeks
- Custom processing or additional testing: longer lead time may apply
Actual terms depend on inventory, specification, testing scope, packaging, destination, and shipping arrangements.
How to Compare Risk-Adjusted Cost
The lowest unit price is not always the lowest procurement cost.
A practical comparison should include:
- Material cost: ingredient and packaging
- Logistics cost: freight, insurance, duties, and customs
- Quality cost: samples, testing, and audits
- Inventory cost: lead time, safety stock, and financing
- Failure cost: rejection, downtime, rework, and complaints
Compare offers only after confirming an equivalent grade, specification, manufacturing source, package quantity, Incoterm, documentation package, and remaining shelf life.
A higher-priced beta-alanine powder may provide a lower total cost when it offers stronger documentation, more consistent physical properties, shorter replenishment time, and fewer manufacturing disruptions.
Final Procurement Checklist
Before approving a commercial order, confirm that:
- Identity and manufacturing source are defined.
- Identity and assay methods are approved.
- The COA contains actual lot-specific results.
- Process and contaminant risks have been assessed.
- Physical properties fit the dosage form.
- A representative sample has passed testing.
- Pilot performance is acceptable where required.
- Manufacturing and testing locations are disclosed.
- Documents, packaging, MOQ, lead time, and shelf life are confirmed.
- Change control and incoming-lot monitoring are documented.
Request Specifications, Sample, and Bulk Quote
A defensible beta-alanine powder purchasing decision combines analytical quality, powder performance, supplier transparency, and commercial continuity.
Essencefield supports B2B inquiries involving sports nutrition powders, amino acid blends, capsules, tablets, sachets, stick packs, and beverage formulations. Available project support may include specification review, sample coordination, COA/TDS/SDS support, particle-size discussion, testing coordination, packaging planning, and bulk supply evaluation.
For an accurate technical review and quotation, provide:
- Intended application
- Dosage form
- Destination market
- Required assay and quality limits
- Estimated order quantity
- Packaging preference
- Testing and documentation requirements
- Delivery destination
- Expected timeline
Contact Essencefield to request the current specification, representative COA, available sample, packaging details, and commercial quotation.

















